Shikha Jha: My Takeaways from the 4th GANSID International Congress
Shikha Jha, Program Management Consultant at Novo Nordisk Haemophilia and Haemoglobinopathies Foundation, shared a post on LinkedIn:
“I got the opportunity to attend the 4th GANSID International Congress in Hyderabad from October 23–25.
It was a privilege to engage with the clinicians, researchers, patient advocates and policy makers who are driving the future of care for sickle cell disease and other inherited blood disorders worldwide.
The congress highlighted the need for integrated, patient-centred solutions and the power of collaboration in bridging the gap between scientific innovation and access.
Seeing the shared commitment to improving the lives of patients across the world reinforces the importance of the work we do at the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation.
A sincere thank you to the organizers and partners for a few insightful days of learning and strategic dialogue.”

Stay updated with Hemostasis Today.
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support
-
Nov 17, 2026, 23:34Ahmed Bennis: Is Aspirin Therapy Enough for VTE Prevention After Arthroplasty?